In the News

MilliporeSigma Announces Investment in India with New Life Science Manufacturing & Distribution Centre

• Investment near Mumbai to enhance the company’s manufacturing and distribution in the country
• Supports growing demand for biopharmaceutical research and manufacturing in India

Mumbai, India, February 22, 2018 — MilliporeSigma, a leading science and technology company, today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business. The new centre, located in the Patalganga industrial area, near Mumbai, is expected to be completed in 2019. Occupying 10 acres, the site spans more than 12,000 square meters with added gross domestic product storage capacity to meet future growth, further improving inventory availability and reducing lead times.

“In biopharmaceutical research, time is of essence,” said Udit Batra, Member of the MilliporeSigma Executive Board and CEO, Life Science. “Our multiple investments in important Asian markets, including this most recent investment in India, will ensure that our customers have ready access to the products needed to develop new therapies and biosimilars, accelerating access to health.”

MilliporeSigma’s new facility will house a Solids Down-filling operation, giving the Life Science business a competitive advantage through improved fill rates and increased capacity. Addition of this facility to the existing MilliporeSigma facility in Jigani, Bengaluru will significantly strengthen Life Science's overall manufacturing and supply chain infrastructure in the country, allowing for faster and more reliable delivery service. MilliporeSigma research capabilities in India were enhanced in [year], with the opening of the M Lab Collaboration Center in Bangalore.

The Mumbai project announced today is part of MilliporeSigma’s overall €40 million investment in building a robust manufacturing and distribution platform in Asia over the next two years.